464 related articles for article (PubMed ID: 29096683)
21. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
22. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
Schmidt-Wolf R; Zissel G
Anticancer Res; 2020 Jun; 40(6):3097-3108. PubMed ID: 32487604
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
[TBL] [Abstract][Full Text] [Related]
24. Calycosin stimulates proliferation of estrogen receptor-positive human breast cancer cells through downregulation of Bax gene expression and upregulation of Bcl-2 gene expression at low concentrations.
Chen J; Xiong WB; Xiong Y; Wu YY; Chen XJ; Shao ZJ; Liu LT; Kuang WJ; Tan XS; Zhou LM
JPEN J Parenter Enteral Nutr; 2011 Nov; 35(6):763-9. PubMed ID: 21799188
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
Girgert R; Emons G; Gründker C
Breast Cancer Res Treat; 2012 Jul; 134(1):199-205. PubMed ID: 22290080
[TBL] [Abstract][Full Text] [Related]
26. Regulation of HRG-β1-induced proliferation, migration and invasion of MCF-7 cells by upregulation of GPR30 expression.
Ruan SQ; Wang SW; Wang ZH; Zhang SZ
Mol Med Rep; 2012 Jul; 6(1):131-8. PubMed ID: 22576740
[TBL] [Abstract][Full Text] [Related]
27. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
28. The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines.
Sandra N; Ester P; Marie-Agnès P; Robert M; Olivier H
Steroids; 2012 Apr; 77(5):542-51. PubMed ID: 22342541
[TBL] [Abstract][Full Text] [Related]
29. Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo.
Chen J; Liu L; Hou R; Shao Z; Wu Y; Chen X; Zhou L
Cancer Lett; 2011 Sep; 308(2):144-51. PubMed ID: 21612861
[TBL] [Abstract][Full Text] [Related]
30. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
31. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
32. Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells.
Chimento A; Casaburi I; Rosano C; Avena P; De Luca A; Campana C; Martire E; Santolla MF; Maggiolini M; Pezzi V; Sirianni R
Mol Nutr Food Res; 2014 Mar; 58(3):478-89. PubMed ID: 24019118
[TBL] [Abstract][Full Text] [Related]
33. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
34. The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells.
Yu X; Filardo EJ; Shaikh ZA
Toxicol Appl Pharmacol; 2010 May; 245(1):83-90. PubMed ID: 20153348
[TBL] [Abstract][Full Text] [Related]
35. GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.
Mo Z; Liu M; Yang F; Luo H; Li Z; Tu G; Yang G
Breast Cancer Res; 2013 Nov; 15(6):R114. PubMed ID: 24289103
[TBL] [Abstract][Full Text] [Related]
36. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
37. Action of methyl-, propyl- and butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells.
Wróbel AM; Gregoraszczuk EŁ
Toxicol Lett; 2015 Oct; 238(2):110-6. PubMed ID: 26253279
[TBL] [Abstract][Full Text] [Related]
38. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
39. GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells.
Liu L; Liu S; Luo H; Chen C; Zhang X; He L; Tu G
Aging (Albany NY); 2021 Jun; 13(12):16178-16197. PubMed ID: 34182538
[TBL] [Abstract][Full Text] [Related]
40. Apple Peel Flavonoid Fraction 4 Suppresses Breast Cancer Cell Growth by Cytostatic and Cytotoxic Mechanisms.
Loung CY; Fernando W; Rupasinghe HPV; Hoskin DW
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
